Koyfin Home > Directory > Health Care > Amicus Therapeutics > Net Debt / EBITDA

Amicus Therapeutics Net Debt / EBITDA Chart (FOLD)

Amicus Therapeutics annual/quarterly Net Debt / EBITDA from 2019 to 2019. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
Other Ratios Metrics:
  • Amicus Therapeutics Total Debt / Capital for the quarter ending September 09, 2018 was $44m a 27.22% increase of 12m year over year
  • Amicus Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $39m a -4.44% decrease of -2m year over year
  • Amicus Therapeutics Total Debt / Equity for the quarter ending September 09, 2018 was $78m a 39.91% increase of 31m year over year
View Chart On Koyfin